a treatment for esophageal bleeding that involves the use of an endoscope and the injection of a sclerosing solution into veins.

In most hospitals, sclerotherapy for esophageal varices is the treatment of choice to stop esophageal bleeding during acute episodes, and to prevent further incidences of bleeding.

Sclerotherapy for esophageal varices has a 20-40% incidence of complications.transient chest pain.difficulty swallowing.fever.allergic reactions.Infection.bleeding of the esophagus.lung problems.protein intoxication.1-2% percent mortality rate.

Before sclerotherapy for esophageal varices, the patient's vital signs and other pertinent data are recorded, an intravenous line is inserted to administer fluid or blood, and a sedative is prescribed.

Sclerotherapy for esophageal varices has a 20-40% incidence of complications and a 1-2% mortality rate. The procedure controls acute bleeding in about 90% of patients